Search research articles
Contact Us
Filters
Showing results (1-10 of 128) with videos related to
Page
of 13
Sort By:
Translational Lung Cancer Research
|
March 26, 2015
Apoptotic agents
Dean A Fennell
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
April 12, 2011
Genetics and molecular biology of mesothelioma
Dean A Fennell
The Lancet. Oncology
|
September 1, 2023
Tumor Treating Fields therapy could potentiate immunotherapy in non-small-cell lung cancer
Dean A Fennell
Lung Cancer (Amsterdam, Netherlands)
|
June 14, 2005
Molecular and Immunological approaches
Dean A Fennell
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 25, 2018
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma
Dean A Fennell
The Lancet. Oncology
|
October 20, 2019
Tumour Treating Fields for mesothelioma: controversy versus opportunity
Dean A Fennell
The Lancet. Oncology
|
May 14, 2018
Targeting the tumour vasculature in mesothelioma
Dean A Fennell
Clinical Lung Cancer
|
November 12, 2003
Bcl-2 as a target for overcoming chemoresistance in small-cell lung cancer
Dean A Fennell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2005
Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation
Dean A Fennell
Oncoscience
|
October 27, 2015
Circumventing HSP90 inhibitors via apoptosis block
Dean A Fennell, Sara Busacca
Page
of 13
Search research articles
Search
Showing results (1-10 of 128) with videos related to
Sort By:
Page
of 13
Translational Lung Cancer Research
|
March 26, 2015
Apoptotic agents
Dean A Fennell
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
April 12, 2011
Genetics and molecular biology of mesothelioma
Dean A Fennell
The Lancet. Oncology
|
September 1, 2023
Tumor Treating Fields therapy could potentiate immunotherapy in non-small-cell lung cancer
Dean A Fennell
Lung Cancer (Amsterdam, Netherlands)
|
June 14, 2005
Molecular and Immunological approaches
Dean A Fennell
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 25, 2018
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma
Dean A Fennell
The Lancet. Oncology
|
October 20, 2019
Tumour Treating Fields for mesothelioma: controversy versus opportunity
Dean A Fennell
The Lancet. Oncology
|
May 14, 2018
Targeting the tumour vasculature in mesothelioma
Dean A Fennell
Clinical Lung Cancer
|
November 12, 2003
Bcl-2 as a target for overcoming chemoresistance in small-cell lung cancer
Dean A Fennell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2005
Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation
Dean A Fennell
Oncoscience
|
October 27, 2015
Circumventing HSP90 inhibitors via apoptosis block
Dean A Fennell, Sara Busacca
Page
of 13